Sanara MedTech IncSMTI
Price$34.88

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $109.8M+26.7% YoYTTM through 30 Jun 2026
Net Income -$32MTTM through 30 Jun 2026
Free Cash Flow $4.5MTTM through 30 Jun 2026

Margins

Current
Gross Margin93.1%
EBITDA Margin10.3%
Operating Margin9.5%
Net Margin-29.2%

Returns

-478.4%ROE
-48.5%ROA
-82.1%ROIC

Balance Sheet Health

Debt / Equity6.59x
Current Ratio2.58x
Net Debt$32.6M
Cash & Equivalents$15.4M

Quality Metrics

Altman Z-Score3.99
Piotroski F-Score5 / 9
FCF Margin4.1%
Rule of 4011.2
Earnings-Beat Rate50.0%

Multi-Year Trend

Revenue
'20'21'22'23'24'25
FY2025: $103.1M
Diluted EPS
'19'20'21'22'23'24'25
FY2025: $-4.36

Dividend

No dividend

Capital Allocation

R&D Spend$5M
Capex Intensity1.1%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.